首页 > 最新文献

Hepatobiliary surgery and nutrition最新文献

英文 中文
Improving performance of robotic liver resections with high technical complexity by Robo-Lap approach 用机器人搭接法提高技术复杂度高的机器人肝脏切除术的性能
IF 8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-01 DOI: 10.21037/hbsn-23-378
Francesca Ratti, R. Marino, Aldrighetti Luca
{"title":"Improving performance of robotic liver resections with high technical complexity by Robo-Lap approach","authors":"Francesca Ratti, R. Marino, Aldrighetti Luca","doi":"10.21037/hbsn-23-378","DOIUrl":"https://doi.org/10.21037/hbsn-23-378","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"44 4","pages":""},"PeriodicalIF":8.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138626576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of immunosuppressive drugs on natural killer cells in therapeutic drug exposure in liver transplantation. 肝移植治疗药物暴露中免疫抑制药物对自然杀伤细胞的影响
2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-01 Epub Date: 2023-02-28 DOI: 10.21037/hbsn-22-438
Rongrong Qin, Jiwei Qin, Xuefeng Li, Zhijun Xu, Peiqi He, Xiaodong Yuan, Cheng Sun, Björn Nashan

Background: Natural killer (NK) cells are enriched in the liver and are the main regulators in liver transplantation regarding rejection or tolerance, viral infection, or tumor recurrence. Immunosuppression consists of a triple drug standard regimen comprising tacrolimus (TAC) and corticosteroids (CS) with either mycophenolate mofetil (MMF) or sirolimus (SIR)/everolimus (EVE). The aim of this study was to evaluate the impact of trough levels of these regimens under clinical conditions and exposure on human NK-cell activity and function in order to better understand the antiviral and anti-tumor effects of mammalian target of rapamycin inhibitor (mTORI).

Methods: Peripheral blood mononuclear cells (PBMCs) were collected from liver transplant recipients and healthy controls. Number and phenotypes of NK cells in vivo were analyzed by flow cytometry. In this study we simulated the immunosuppressive microenvironment in vitro. PBMCs were cultured at the clinically effective plasma concentration of drugs for 3 d to detect the effect of immunosuppressants on NK cells. Drug type and concentration: single drug [EVE, 5 ng/mL; SIR, 5 ng/mL; TAC, 5 ng/mL; cyclosporine A (CSA), 125 ng/mL; MMF, 15 µg/mL; CS, 0.5 µg/mL] and combined immunosuppressants (Group 1: TAC, 5 ng/mL + MMF, 15 µg/mL + CS, 0.5 µg/mL; Group 2: TAC, 5 ng/mL + SIR, 5 ng/mL + CS, 0.5 µg/mL; Group 3: TAC, 5 ng/mL + EVE, 5 ng/mL + CS, 0.5 µg/mL). In addition, NK cells were sorted from PBMCs and treated under the above conditions to detect NK cell killing function and RNA transcription characteristics.

Results: CS significantly impaired the cytolytic activity of NK cells, followed by MMF and SIR/EVE. CS and TAC/CSA significantly decreased the secretion of IFN-γ and CD107a. NK cell function in liver transplant recipients was most pronouncedly inhibited by a triple immunosuppressive regimen, with CS playing the most prominent role compared with the other drugs. The MMF-containing regimen demonstrated a significant increase in the expression of suppressive genes, especially of the Siglec7/9 family. The SIR group had stronger NK cell activity compared with that of the MMF group, although liver transplantation patients have lower NK cell activity and function.

Conclusions: Despite an overall comparable immunosuppressive efficiency in terms of prevention of acute rejection, a mTORIs-including regimen might be considered as having less impact on NK cell function.

背景:自然杀伤(NK)细胞富集于肝脏,是肝脏移植排斥或耐受、病毒感染或肿瘤复发的主要调节因子。免疫抑制包括由他克莫司(TAC)、皮质类固醇(CS)和霉酚酸酯(MMF)或西罗莫司(SIR)/依维莫司(EVE)组成的三联药物标准方案。本研究的目的是评估这些方案在临床条件下的谷值水平和暴露对人类 NK 细胞活性和功能的影响,以便更好地了解哺乳动物雷帕霉素靶抑制剂(mTORI)的抗病毒和抗肿瘤作用:方法:收集肝移植受者和健康对照组的外周血单核细胞(PBMCs)。流式细胞术分析了体内 NK 细胞的数量和表型。在这项研究中,我们在体外模拟了免疫抑制微环境。在临床有效药物血浆浓度下培养 PBMC 3 d,以检测免疫抑制剂对 NK 细胞的影响。药物类型和浓度:单一药物[EVE,5 ng/mL;SIR,5 ng/mL;TAC,5 ng/mL;环孢素A(CSA),125 ng/mL;MMF,15 µg/mL;CS,0.5 µg/mL] 和联合免疫抑制剂(第 1 组:TAC,5 ng/mL + MMF,15 µg/mL + CS,0.5 µg/mL;第 2 组:TAC,5 ng/mL + SIR,5 ng/mL + CS,0.5 µg/mL;第 3 组:TAC,5 ng/mL + EVE,5 ng/mL + CS,0.5 µg/mL)。此外,还从 PBMCs 中分拣出 NK 细胞,并在上述条件下进行处理,以检测 NK 细胞的杀伤功能和 RNA 转录特征:结果:CS明显降低了NK细胞的细胞溶解活性,其次是MMF和SIR/EVE。CS 和 TAC/CSA 能明显降低 IFN-γ 和 CD107a 的分泌。三联免疫抑制方案对肝移植受者NK细胞功能的抑制最为明显,与其他药物相比,CS的作用最为突出。含 MMF 的方案显示抑制基因的表达显著增加,尤其是 Siglec7/9 家族。与 MMF 组相比,SIR 组的 NK 细胞活性更强,尽管肝移植患者的 NK 细胞活性和功能较低:结论:尽管在预防急性排斥反应方面的免疫抑制效率总体相当,但可以认为包括mTORI的方案对NK细胞功能的影响较小。
{"title":"Influence of immunosuppressive drugs on natural killer cells in therapeutic drug exposure in liver transplantation.","authors":"Rongrong Qin, Jiwei Qin, Xuefeng Li, Zhijun Xu, Peiqi He, Xiaodong Yuan, Cheng Sun, Björn Nashan","doi":"10.21037/hbsn-22-438","DOIUrl":"10.21037/hbsn-22-438","url":null,"abstract":"<p><strong>Background: </strong>Natural killer (NK) cells are enriched in the liver and are the main regulators in liver transplantation regarding rejection or tolerance, viral infection, or tumor recurrence. Immunosuppression consists of a triple drug standard regimen comprising tacrolimus (TAC) and corticosteroids (CS) with either mycophenolate mofetil (MMF) or sirolimus (SIR)/everolimus (EVE). The aim of this study was to evaluate the impact of trough levels of these regimens under clinical conditions and exposure on human NK-cell activity and function in order to better understand the antiviral and anti-tumor effects of mammalian target of rapamycin inhibitor (mTORI).</p><p><strong>Methods: </strong>Peripheral blood mononuclear cells (PBMCs) were collected from liver transplant recipients and healthy controls. Number and phenotypes of NK cells <i>in vivo</i> were analyzed by flow cytometry. In this study we simulated the immunosuppressive microenvironment <i>in vitro</i>. PBMCs were cultured at the clinically effective plasma concentration of drugs for 3 d to detect the effect of immunosuppressants on NK cells. Drug type and concentration: single drug [EVE, 5 ng/mL; SIR, 5 ng/mL; TAC, 5 ng/mL; cyclosporine A (CSA), 125 ng/mL; MMF, 15 µg/mL; CS, 0.5 µg/mL] and combined immunosuppressants (Group 1: TAC, 5 ng/mL + MMF, 15 µg/mL + CS, 0.5 µg/mL; Group 2: TAC, 5 ng/mL + SIR, 5 ng/mL + CS, 0.5 µg/mL; Group 3: TAC, 5 ng/mL + EVE, 5 ng/mL + CS, 0.5 µg/mL). In addition, NK cells were sorted from PBMCs and treated under the above conditions to detect NK cell killing function and RNA transcription characteristics.</p><p><strong>Results: </strong>CS significantly impaired the cytolytic activity of NK cells, followed by MMF and SIR/EVE. CS and TAC/CSA significantly decreased the secretion of IFN-γ and CD107a. NK cell function in liver transplant recipients was most pronouncedly inhibited by a triple immunosuppressive regimen, with CS playing the most prominent role compared with the other drugs. The MMF-containing regimen demonstrated a significant increase in the expression of suppressive genes, especially of the Siglec7/9 family. The SIR group had stronger NK cell activity compared with that of the MMF group, although liver transplantation patients have lower NK cell activity and function.</p><p><strong>Conclusions: </strong>Despite an overall comparable immunosuppressive efficiency in terms of prevention of acute rejection, a mTORIs-including regimen might be considered as having less impact on NK cell function.</p>","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"1 1","pages":"835-853"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10727815/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42379295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Futibatinib: new targeted therapy in intrahepatic cholangiocarcinoma 福替替尼:肝内胆管癌的新型靶向疗法
IF 8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-01 DOI: 10.21037/hbsn-23-476
Rita Khoury, N. Khalife, Rebecca Ibrahim, Khalil Saleh
{"title":"Futibatinib: new targeted therapy in intrahepatic cholangiocarcinoma","authors":"Rita Khoury, N. Khalife, Rebecca Ibrahim, Khalil Saleh","doi":"10.21037/hbsn-23-476","DOIUrl":"https://doi.org/10.21037/hbsn-23-476","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":" 9","pages":""},"PeriodicalIF":8.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138617988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fatty liver disease and risk of all cause and cause-specific mortality outcomes in the older population 脂肪肝与老年人群各种死因和特定死因的死亡风险
IF 8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-01 DOI: 10.21037/hbsn-23-542
Josh Bilson, Christopher D. Byrne
{"title":"Fatty liver disease and risk of all cause and cause-specific mortality outcomes in the older population","authors":"Josh Bilson, Christopher D. Byrne","doi":"10.21037/hbsn-23-542","DOIUrl":"https://doi.org/10.21037/hbsn-23-542","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":" 14","pages":""},"PeriodicalIF":8.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138618113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The significance of severe postoperative complications on liver regeneration 术后严重并发症对肝脏再生的影响
IF 8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-01 DOI: 10.21037/hbsn-23-487
Yanfang Zhang, Liangliang Xu, Ming-Qin Xu
{"title":"The significance of severe postoperative complications on liver regeneration","authors":"Yanfang Zhang, Liangliang Xu, Ming-Qin Xu","doi":"10.21037/hbsn-23-487","DOIUrl":"https://doi.org/10.21037/hbsn-23-487","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"70 s287","pages":""},"PeriodicalIF":8.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138622005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modern surgical approach to hepatocellular carcinoma 肝细胞癌的现代外科治疗方法
IF 8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-01 DOI: 10.21037/hbsn-23-535
P. Magistri, G. Guerrini, S. Di Sandro, F. di Benedetto
{"title":"Modern surgical approach to hepatocellular carcinoma","authors":"P. Magistri, G. Guerrini, S. Di Sandro, F. di Benedetto","doi":"10.21037/hbsn-23-535","DOIUrl":"https://doi.org/10.21037/hbsn-23-535","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":" 21","pages":""},"PeriodicalIF":8.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138612991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary hospitals in China: current state, challenges, and solutions 中国的基层医院:现状、挑战和解决方案
IF 8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-01 DOI: 10.21037/hbsn-23-571
Ziyi Wang, Ge Zhang
{"title":"Primary hospitals in China: current state, challenges, and solutions","authors":"Ziyi Wang, Ge Zhang","doi":"10.21037/hbsn-23-571","DOIUrl":"https://doi.org/10.21037/hbsn-23-571","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":" 33","pages":""},"PeriodicalIF":8.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138616310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Managing portal hypertension in patients with liver cirrhosis and hepatocellular carcinoma: non-invasive diagnosis and systemic treatment considerations 肝硬化和肝细胞癌患者的门静脉高压管理:无创诊断和系统治疗注意事项
IF 8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-01 DOI: 10.21037/hbsn-23-551
Woo Kyoung Jeong
{"title":"Managing portal hypertension in patients with liver cirrhosis and hepatocellular carcinoma: non-invasive diagnosis and systemic treatment considerations","authors":"Woo Kyoung Jeong","doi":"10.21037/hbsn-23-551","DOIUrl":"https://doi.org/10.21037/hbsn-23-551","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":" 9","pages":""},"PeriodicalIF":8.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138617559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New insights in the metabolic function related to gut microbiota in the process of liver regeneration 肝脏再生过程中与肠道微生物群相关的代谢功能新发现
IF 8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-01 DOI: 10.21037/hbsn-23-508
Nan Jiang, Zhen Wang, Kefei Yuan
{"title":"New insights in the metabolic function related to gut microbiota in the process of liver regeneration","authors":"Nan Jiang, Zhen Wang, Kefei Yuan","doi":"10.21037/hbsn-23-508","DOIUrl":"https://doi.org/10.21037/hbsn-23-508","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"103 9","pages":""},"PeriodicalIF":8.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138608977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-organ cutaneous metastasis of rectal signet ring cell carcinoma 直肠标志环细胞癌的单器官皮肤转移
IF 8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-01 DOI: 10.21037/hbsn-23-451
Wenqing Jia, Zichao Guo, Xi Cheng, Ren Zhao
{"title":"Single-organ cutaneous metastasis of rectal signet ring cell carcinoma","authors":"Wenqing Jia, Zichao Guo, Xi Cheng, Ren Zhao","doi":"10.21037/hbsn-23-451","DOIUrl":"https://doi.org/10.21037/hbsn-23-451","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"4 11","pages":""},"PeriodicalIF":8.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138625345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hepatobiliary surgery and nutrition
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1